CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Current status of immune checkpoint inhibitors in treatment of non-small cell lung cancer
Sung Won Lim, Myung-Ju Ahn
Korean J Intern Med. 2019;34(1):50-59.   Published online 2018 September 3    DOI: https://doi.org/10.3904/kjim.2018.179

Excel Download

Current status of immune checkpoint inhibitors in treatment of non-small cell lung cancer
The Korean Journal of Internal Medicine. 2019;34(1):50-59   Crossref logo
Link1 Link2 Link3

Mechanisms of immune evasion and current status of checkpoint inhibitors in non-small cell lung cancer
Cancer Medicine. 2016;5(9):2567-2578   Crossref logo
Link1 Link2

Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer
Current Treatment Options in Oncology. 2018;19(8):   Crossref logo
Link1 Link2 Link3

Immune checkpoint inhibitors in non-small cell lung cancer (NSCLC): Approaches on special subgroups and unresolved burning questions
Cancer Treatment Reviews. 2018;64:21-29   Crossref logo
Link1 Link2

THE SUM OF TUMOR SIZE PREDICTS THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN NON-SMALL CELL LUNG CANCER
Respirology. 2018;23:289-289   Crossref logo
Link1 Link2

Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non–small cell lung cancer
Lung Cancer. 2016;99:79-87   Crossref logo
Link1 Link2

Immune Checkpoint Inhibitors for Patients With Advanced Non–Small-Cell Lung Cancer: A Systematic Review
Clinical Lung Cancer. 2017;18(5):444-459.e1   Crossref logo
Link1 Link2

Corrigendum to “Immune-checkpoint inhibition in first-line treatment of advanced non-small cell lung cancer patients: Current status and future approaches” [Lung Cancer 106 (2017) 70–75]
Lung Cancer. 2018;117:80   Crossref logo
Link1 Link2

Immune checkpoint inhibitors: the new frontier in non–small cell lung cancer treatment
OncoTargets and Therapy. 2016;Volume 9:5101-5116   Crossref logo
Link1

First-Line Treatment of Non-Small-Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors
BioDrugs. 2019;   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.